Hanadi Ajam Oughli, MD
Psychiatry · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 13 years
- Graduated 2013
Offices
3 locations · UC Regents · 148 clinicians in this group
Hospitals listed: Santa Monica - UCLA Med Ctr & Orthopaedic Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Oughli’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Monica - UCLA Med Ctr & Orthopaedic HospitalSanta Monica, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.09 (0 to 0.59) · 6,805 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.667, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.6 to 1) · 1,274 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Santa Monica - UCLA Med Ctr & Orthopaedic Hospital
Behind the star rating — Deaths: 3 better, 4 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 7 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.09 (0 to 0.59) · 6,805 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.667 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 1,274 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.87 (0 to 1.75) · 1,532 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.76 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.96 (97.85 to 194.07) · 118 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 87 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.4 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.1 · 295 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.4 · 497 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 100 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 2,432 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 7,694 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.07 to 0.44) · 8,081 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.95 (3.16 to 6.74) · 1,949 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.82 (0.22 to 3.41) · 915 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.63 (0.18 to 3.08) · 1,832 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.05 (4.53 to 17.57) · 886 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.16 (5.05 to 11.26) · 893 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.62 (0.15 to 3.09) · 396 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 336 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.902 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.479 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.612 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.274 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 99 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 57.2 · 67 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 386 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 41.3 · 584 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 605 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.1 to 7.3) · 81 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.5 to 14.8) · 81 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 304 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.2 (9.5 to 15.5) · 1,955 cases | No different | Jan 2022 – Dec 2024 |
What patients said (639 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$73,404
Medicare paid this office $73,404 for 200 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 78 | $23,419 | $101 |
| Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | 22 | $12,949 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $8,288 | $70 |
| Psychotherapy with evaluation and management visit, 30 minutes | 35 | $8,116 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $5,508 | $153 |
See all 7 services
| Return visit (30+ min) | 78 | $23,419 | $101 |
| Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | 22 | $12,949 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $8,288 | $70 |
| Psychotherapy with evaluation and management visit, 30 minutes | 35 | $8,116 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $5,508 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $4,759 | $101 |
| New patient visit (60+ min) | 14 | $2,641 | $189 |
Who their Medicare patients are
200 Original Medicare patients in 2024. Average age 73 · Under 65 14% · 85 and older 13% · Women 61% · Also on Medicaid 36% · Health risk score 1.92. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 70% · Dementia 37% · Coronary heart disease 33% · Diabetes 30% · Chronic kidney disease 30% · Heart failure 25% · COPD 20% · Atrial fibrillation 18% · Cancer 17% · Stroke 13%.
The office billed $613,333, Medicare allowed $94,157 and paid $73,404; for 798 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 200 | 798 | 73 | 1.92 | $613,333 | $73,404 |
| 2023 | 222 | 786 | 70 | 2.27 | $522,914 | $71,919 |
| 2022 | 195 | 738 | 73 | 2.16 | $443,217 | $61,136 |
| 2021 | 239 | 740 | 73 | 1.96 | $524,178 | $75,821 |
| 2020 | 103 | 267 | 74 | 2.14 | $130,891 | $25,524 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 85 | $27,812 | $109 |
| Psychotherapy with evaluation and management visit, 30 minutes | 47 | $10,667 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $9,238 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $7,654 | $144 |
| Long return visit (40+ min) | 12 | $2,053 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,035 | $62 |
| Short return visit (20+ min) | 13 | $1,683 | $73 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,200 | $63 |
2022: 10 services
| Return visit (30+ min) | 80 | $24,611 | $104 |
| Psychotherapy with evaluation and management visit, 30 minutes | 56 | $10,840 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $7,495 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $6,707 | $168 |
| New patient visit (45+ min) | 14 | $1,761 | $126 |
| Long return visit (40+ min) | 11 | $1,589 | $132 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,370 | $76 |
| Short return visit (20+ min) | 18 | $1,294 | $65 |
| Psychiatric services complicated by communication factor | 19 | $684 | $12 |
| Short return visit | 13 | $396 | $28 |
2021: 9 services
| Return visit (30+ min) | 104 | $27,878 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 64 | $11,230 | $170 |
| Psychotherapy with evaluation and management visit, 30 minutes | 62 | $9,924 | $60 |
| New patient visit (45+ min) | 46 | $6,175 | $134 |
| New patient visit (60+ min) | 27 | $5,052 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $4,970 | $87 |
| Telephone medical discussion with physician, 21-30 minutes | 33 | $3,288 | $76 |
| Short return visit (20+ min) | 14 | $1,494 | $79 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $1,226 | $58 |
2020: 7 services
| Return visit (30+ min) | 43 | $6,394 | $97 |
| New patient visit (45+ min) | 27 | $3,861 | $143 |
| Psychotherapy with evaluation and management visit, 30 minutes | 31 | $3,484 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,405 | $170 |
| New patient visit (60+ min) | 16 | $2,868 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,496 | $94 |
| Psychiatric services complicated by communication factor | 15 | $331 | $13 |
Drugs they prescribed that Part D paid
$52,309
Pharmacies billed $52,309 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
930 generic and 43 brand-name prescriptions · $52,309 in drug cost · 116 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Aripiprazole | 37 | $6,092 | $165 |
| Venlafaxine Hcl Er | 31 | $2,091 | $67 |
| Bupropion Xl | 63 | $1,489 | $24 |
| Trazodone | 49 | $1,358 | $28 |
| Dextroamphetamine-Amphet Er | 17 | $1,245 | $73 |
See all 21 drugs
| Aripiprazole | 37 | $6,092 | $165 |
| Venlafaxine Hcl Er | 31 | $2,091 | $67 |
| Bupropion Xl | 63 | $1,489 | $24 |
| Trazodone | 49 | $1,358 | $28 |
| Dextroamphetamine-Amphet Er | 17 | $1,245 | $73 |
| Escitalopram | 82 | $1,210 | $15 |
| Olanzapine | 36 | $1,205 | $33 |
| Duloxetine | 31 | $1,202 | $39 |
| Clonazepam | 49 | $1,153 | $24 |
| Mirtazapine | 45 | $1,031 | $23 |
| Gabapentin | 90 | $882 | $10 |
| Quetiapine | 45 | $867 | $19 |
| Sertraline | 66 | $636 | $10 |
| Risperidone | 22 | $551 | $25 |
| Lamotrigine | 36 | $534 | $15 |
| Modafinil | 11 | $412 | $37 |
| Buspirone | 25 | $277 | $11 |
| Lithium Carbonate Er | 12 | $240 | $20 |
| Fluoxetine | 34 | $198 | $6 |
| Alprazolam | 36 | $173 | $5 |
| Lorazepam | 15 | $107 | $7 |
Year by year
| 2024 | 973 | 93 | None | 4% | $52,309 |
| 2023 | 1,207 | 104 | 0% (0) | 3% | $54,083 |
| 2022 | 1,046 | 114 | 0% (0) | 3% | $70,871 |
| 2021 | 888 | 123 | 0% (0) | 4% | $28,344 |
| 2020 | 383 | 88 | 0% (0) | 3% | $21,898 |
| 2019 | 179 | 36 | 0% (0) | None | $7,988 |
| 2018 | 408 | 43 | 0% (0) | 3% | $26,547 |
| 2017 | 223 | 45 | 0% (0) | None | $15,416 |
| 2016 | 41 | 16 | None | None | $1,167 |
| 2015 | 38 | None | None | None | $1,267 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Trintellix | 11 | $7,554 | $687 |
| Aripiprazole | 53 | $5,236 | $99 |
| Bupropion Xl | 89 | $4,059 | $46 |
| Venlafaxine Hcl Er | 51 | $2,559 | $50 |
| Olanzapine | 44 | $2,232 | $51 |
| Escitalopram | 93 | $1,564 | $17 |
| Mirtazapine | 84 | $1,515 | $18 |
| Sertraline | 76 | $1,273 | $17 |
| Buspirone | 61 | $1,230 | $20 |
| Trazodone | 68 | $1,116 | $16 |
| Quetiapine | 53 | $1,046 | $20 |
| Gabapentin | 73 | $855 | $12 |
| Duloxetine | 28 | $656 | $23 |
| Risperidone | 26 | $540 | $21 |
| Lamotrigine | 39 | $492 | $13 |
| Imipramine | 11 | $459 | $42 |
| Fluoxetine | 49 | $380 | $8 |
| Clonazepam | 49 | $331 | $7 |
| Alprazolam | 29 | $241 | $8 |
| Lorazepam | 31 | $199 | $6 |
| Divalproex | 11 | $138 | $13 |
| Lithium Carbonate Er | 11 | $115 | $10 |
| Doxepin | 22 | $96 | $4 |
2022: 20 drugs
| Aripiprazole | 41 | $9,293 | $227 |
| Olanzapine | 55 | $4,395 | $80 |
| Bupropion Xl | 69 | $4,095 | $59 |
| Quetiapine | 57 | $1,555 | $27 |
| Trazodone | 80 | $1,518 | $19 |
| Escitalopram | 102 | $1,251 | $12 |
| Sertraline | 56 | $1,156 | $21 |
| Duloxetine | 38 | $1,098 | $29 |
| Mirtazapine | 51 | $910 | $18 |
| Venlafaxine Hcl Er | 42 | $891 | $21 |
| Gabapentin | 73 | $760 | $10 |
| Buspirone | 45 | $657 | $15 |
| Fluoxetine | 38 | $521 | $14 |
| Divalproex | 22 | $504 | $23 |
| Risperidone | 28 | $425 | $15 |
| Alprazolam | 27 | $247 | $9 |
| Lamotrigine | 17 | $134 | $8 |
| Lorazepam | 27 | $121 | $4 |
| Clonazepam | 16 | $113 | $7 |
| Doxepin | 13 | $57 | $4 |
2021: 21 drugs
| Aripiprazole | 35 | $3,485 | $100 |
| Bupropion Xl | 50 | $2,065 | $41 |
| Escitalopram | 105 | $1,988 | $19 |
| Mirtazapine | 59 | $1,319 | $22 |
| Olanzapine | 38 | $1,178 | $31 |
| Methylphenidate Hcl Cd | 11 | $1,056 | $96 |
| Venlafaxine Hcl Er | 48 | $1,035 | $22 |
| Quetiapine | 55 | $1,024 | $19 |
| Duloxetine | 31 | $845 | $27 |
| Doxepin | 12 | $605 | $50 |
| Trazodone | 54 | $588 | $11 |
| Gabapentin | 71 | $564 | $8 |
| Memantine | 15 | $470 | $31 |
| Sertraline | 42 | $436 | $10 |
| Fluoxetine | 35 | $352 | $10 |
| Buspirone | 30 | $242 | $8 |
| Risperidone | 16 | $169 | $11 |
| Donepezil | 13 | $131 | $10 |
| Alprazolam | 19 | $123 | $6 |
| Lorazepam | 23 | $109 | $5 |
| Citalopram Hbr | 11 | $108 | $10 |
2020: 12 drugs
| Aripiprazole | 17 | $2,898 | $170 |
| Duloxetine | 37 | $1,680 | $45 |
| Mirtazapine | 22 | $933 | $42 |
| Bupropion Xl | 17 | $627 | $37 |
| Venlafaxine Hcl Er | 28 | $533 | $19 |
| Quetiapine | 23 | $432 | $19 |
| Sertraline | 24 | $409 | $17 |
| Olanzapine | 18 | $271 | $15 |
| Gabapentin | 35 | $258 | $7 |
| Buspirone | 11 | $211 | $19 |
| Escitalopram | 23 | $187 | $8 |
| Trazodone | 21 | $107 | $5 |
2019: 5 drugs
| Duloxetine | 16 | $1,013 | $63 |
| Mirtazapine | 17 | $295 | $17 |
| Sertraline | 22 | $249 | $11 |
| Quetiapine | 16 | $242 | $15 |
| Gabapentin | 14 | $119 | $9 |
2018: 13 drugs
| Aripiprazole | 23 | $3,319 | $144 |
| Bupropion Xl | 40 | $1,836 | $46 |
| Duloxetine | 30 | $1,620 | $54 |
| Clozapine | 15 | $906 | $60 |
| Risperidone | 33 | $304 | $9 |
| Mirtazapine | 19 | $229 | $12 |
| Olanzapine | 19 | $224 | $12 |
| Sertraline | 29 | $222 | $8 |
| Trazodone | 25 | $150 | $6 |
| Clonazepam | 19 | $134 | $7 |
| Benztropine Mesylate | 15 | $124 | $8 |
| Citalopram Hbr | 18 | $89 | $5 |
| Lithium Carbonate | 14 | $32 | $2 |
2017: 7 drugs
| Aripiprazole | 18 | $3,293 | $183 |
| Bupropion Xl | 19 | $796 | $42 |
| Clozapine | 12 | $753 | $63 |
| Olanzapine | 20 | $224 | $11 |
| Risperidone | 19 | $152 | $8 |
| Sertraline | 12 | $100 | $8 |
| Citalopram Hbr | 12 | $45 | $4 |
Money from drug and device companies
$59 in 2022
A payment is not proof that care is biased.
| Janssen Research & Development | None | $59 | 1 payment
|
See the published payment
| Janssen Research & Development | Meals · 2022-11-14 | None | $59 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1598149536
- Licence
- MO 2015013423
- Group
- UC Regents
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
- NPI first listed
- 2015-07-18
- NPI last updated
- 2024-07-16
- NPI record certified
- 2024-07-16
This is when the NPI record was last certified, not a medical board exam.